alpha-1-antitrypsin

Approximately 10% of infants who have alpha-1-antitrypsin deficiency develop neonatal cholestasis. Although most of the affected infants become asymptomatic within the first year of life, a small percentage develops cirrhosis and portal hypertension that requires liver transplant.